Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by stockarchangelon Nov 27, 2013 12:38pm

118 Views

Post# 21946531

RE:RE:I wonder what else Bloom and Sirona have up their sleeves

I'm assuming global sales for biopharmaceutical proteins have exceeded US$100 billion (it was close to $90 billion 5 years ago, the last stat I could find). How much are the inducers worth? I'm thinking at least in the 8-9 figure range, possibly more if the protein is finicky and really popular lol.

Bullboard Posts

Canadian artificial intelligence ETFs